# P. Cacoub

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/p-cacoub/

## Facts

| Field | Value |
| --- | --- |
| Citations | 60,891 |
| Field | Hepatitis C virus research |
| h-index | 122 |
| i10-index | 607 |
| Last Known Institution | Sorbonne Université |
| OpenAlex ID | https://openalex.org/A5037078532 |
| ORCID iD | https://orcid.org/0000-0002-6727-4992 |
| Works | 1,605 |

## Researcher papers

- [Clopidogrel and Aspirin versus Aspirin Alone for the Prevention of Atherothrombotic Events](https://scholariq.org/papers/clopidogrel-and-aspirin-versus-aspirin-alone-for-the-prevention-of/)
- [Kaposi's sarcoma-associated herpesvirus-like DNA sequences in multicentric Castleman's disease \[see comments\]](https://scholariq.org/papers/kaposi-s-sarcoma-associated-herpesvirus-like-dna-sequences-in-multicentric/)
- [Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance physician-reported registry](https://scholariq.org/papers/factors-associated-with-covid-19-related-death-in-people-with-rheumatic-diseases/)
- [Extrahepatic manifestations of chronic hepatitis C](https://scholariq.org/papers/extrahepatic-manifestations-of-chronic-hepatitis-c/)
- [Multicentric Castlemanʼs disease in HIV infection](https://scholariq.org/papers/multicentric-castleman-s-disease-in-hiv-infection/)
- [Pacemaker infective endocarditis](https://scholariq.org/papers/pacemaker-infective-endocarditis/)
- [COVID-19 outcomes in patients with inflammatory rheumatic and musculoskeletal diseases treated with rituximab: a cohort study](https://scholariq.org/papers/covid-19-outcomes-in-patients-with-inflammatory-rheumatic-and-musculoskeletal/)
- [Retrospective Analysis of Surgery Versus Endovascular Intervention in Takayasu Arteritis](https://scholariq.org/papers/retrospective-analysis-of-surgery-versus-endovascular-intervention-in-takayasu/)
- [Long-Term Outcomes and Prognostic Factors of Complications in Takayasu Arteritis](https://scholariq.org/papers/long-term-outcomes-and-prognostic-factors-of-complications-in-takayasu-arteritis/)
- [Long-term efficacy and safety of rituximab in IgG4-related disease: Data from a French nationwide study of thirty-three patients](https://scholariq.org/papers/long-term-efficacy-and-safety-of-rituximab-in-igg4-related-disease-data-from-a/)
- [Critical role of IL-21 in modulating TH17 and regulatory T cells in Behçet disease](https://scholariq.org/papers/critical-role-of-il-21-in-modulating-th17-and-regulatory-t-cells-in-behcet/)
- [Efficacy of anti-TNF alpha in severe and/or refractory Behçet's disease: Multicenter study of 124 patients](https://scholariq.org/papers/efficacy-of-anti-tnf-alpha-in-severe-and-or-refractory-behcet-s-disease/)

## Researcher topics

- [Hepatitis C virus research](https://scholariq.org/topics/hepatitis-c-virus-research/)
- [Vasculitis and related conditions](https://scholariq.org/topics/vasculitis-and-related-conditions-2/)
- [Systemic Lupus Erythematosus Research](https://scholariq.org/topics/systemic-lupus-erythematosus-research/)
- [Liver Disease Diagnosis and Treatment](https://scholariq.org/topics/liver-disease-diagnosis-and-treatment/)
- [Ocular Diseases and Behçet’s Syndrome](https://scholariq.org/topics/ocular-diseases-and-behcet-s-syndrome/)

## Researcher university

- [Sorbonne Université](https://scholariq.org/institutions/sorbonne-universite/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.